Yue Luo

1.7k total citations
47 papers, 1.3k citations indexed

About

Yue Luo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yue Luo has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yue Luo's work include Cancer-related molecular mechanisms research (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and RNA modifications and cancer (6 papers). Yue Luo is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and RNA modifications and cancer (6 papers). Yue Luo collaborates with scholars based in China, United States and Egypt. Yue Luo's co-authors include David C. Ward, Peter E. Schwartz, Yinglei Lai, Thomas Rutherford, Patricia Bray‐Ward, Gil Mor, Irene Visintin, Hongyu Zhao, Cristina Di Poto and Rency S. Varghese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and PLoS ONE.

In The Last Decade

Yue Luo

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue Luo China 18 728 276 168 156 152 47 1.3k
Zhenming Gao China 21 696 1.0× 270 1.0× 104 0.6× 96 0.6× 142 0.9× 53 1.2k
Deguang Sun China 20 1.1k 1.5× 254 0.9× 252 1.5× 91 0.6× 223 1.5× 39 1.4k
Egidio Iorio Italy 30 1.5k 2.1× 708 2.6× 168 1.0× 175 1.1× 296 1.9× 80 2.4k
Fenglin Lv China 21 866 1.2× 100 0.4× 79 0.5× 156 1.0× 80 0.5× 45 1.7k
Jae Won Chang United States 22 1.2k 1.6× 268 1.0× 134 0.8× 240 1.5× 276 1.8× 47 2.3k
Feng Su United States 19 853 1.2× 555 2.0× 298 1.8× 98 0.6× 225 1.5× 39 1.9k
Hüseyin Aktaş United States 19 996 1.4× 98 0.4× 72 0.4× 56 0.4× 327 2.2× 32 2.0k
Arthur T. Kopylov Russia 23 1.1k 1.5× 165 0.6× 282 1.7× 79 0.5× 112 0.7× 158 1.9k
Patrizia Bottoni Italy 21 962 1.3× 388 1.4× 36 0.2× 210 1.3× 443 2.9× 42 1.9k
Cristina Al‐Khalili Szigyarto Sweden 19 1.4k 2.0× 148 0.5× 181 1.1× 63 0.4× 397 2.6× 31 1.8k

Countries citing papers authored by Yue Luo

Since Specialization
Citations

This map shows the geographic impact of Yue Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Luo more than expected).

Fields of papers citing papers by Yue Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Luo. The network helps show where Yue Luo may publish in the future.

Co-authorship network of co-authors of Yue Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Luo. A scholar is included among the top collaborators of Yue Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Luo. Yue Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yue, Haiyan Wu, Hong Wei, Zhenling Peng, & Jianyi Yang. (2025). Predicting the Oligomeric State of Proteins Using Multiple Templates Detected by Complementary Alignment Methods. Proteins Structure Function and Bioinformatics. 93(12). 2138–2149. 2 indexed citations
2.
Luo, Yue, Kepeng Qiu, Tianhua Xu, Fuli Zhang, & Yue Peng. (2025). Design of a novel multiband terahertz metamaterial absorber using a deep learning framework. Engineering Applications of Artificial Intelligence. 151. 110801–110801. 2 indexed citations
3.
Luo, Yue, Lei Zhang, & Xiangcheng Zheng. (2025). Accelerated High-Index Saddle Dynamics Method for Searching High-Index Saddle Points. Journal of Scientific Computing. 102(2).
4.
Wang, Qing, Jia Wang, Wenjun Li, et al.. (2023). Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China. Frontiers in Immunology. 14. 1191479–1191479. 1 indexed citations
5.
Zhang, Jiakang, Dayong Zheng, Yue Luo, et al.. (2023). Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC. Biomedicines. 11(3). 695–695. 4 indexed citations
6.
7.
Liu, Xinhui, Wan Zhang, Yue Luo, et al.. (2022). Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2. Journal of Translational Medicine. 20(1). 21 indexed citations
8.
Luo, Yue, Kepeng Qiu, Ziad Moumni, et al.. (2022). Chiral metasurface design with highly efficient and controllable asymmetric transmission and perfect polarization conversion of linearly polarized electromagnetic waves in the THz range. Journal of Physics D Applied Physics. 55(29). 295303–295303. 11 indexed citations
9.
Zhang, Jiakang, et al.. (2022). AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma. Cancers. 14(19). 4600–4600. 11 indexed citations
10.
Luo, Yue, et al.. (2021). LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 9990338–9990338. 16 indexed citations
11.
Ru, Yi, Xiaojie Ding, Ying Luo, et al.. (2021). Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms. Frontiers in Immunology. 12. 670398–670398. 23 indexed citations
12.
Wei, Jiazhang, Jiaxiang Ye, Yue Luo, et al.. (2020). EB virus promotes metastatic potential by boosting STIM1-dependent Ca2+ signaling in nasopharyngeal carcinoma cells. Cancer Letters. 478. 122–132. 13 indexed citations
13.
Huang, Chengzhi, et al.. (2019). Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. BMC Pharmacology and Toxicology. 20(1). 72–72. 23 indexed citations
14.
Zhang, Wan, Jianpeng Xiao, Xinhui Liu, et al.. (2019). Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma. Journal of Cancer. 10(11). 2578–2587. 30 indexed citations
15.
Poto, Cristina Di, Alessia Ferrarini, Yi Zhao, et al.. (2016). Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery. Cancer Epidemiology Biomarkers & Prevention. 26(5). 675–683. 42 indexed citations
16.
Ranjbar, Mohammad, Yue Luo, Cristina Di Poto, et al.. (2015). GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort. PLoS ONE. 10(6). e0127299–e0127299. 67 indexed citations
17.
Ghosh, Sanchita, Rajbir Singh, Kushal Chakraborty, et al.. (2013). Metabolomic changes in gastrointestinal tissues after whole body radiation in a murine model. Molecular BioSystems. 9(4). 723–731. 23 indexed citations
18.
Rizk, Nasser, et al.. (2012). Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes. Molecular BioSystems. 9(2). 307–317. 43 indexed citations
19.
Xiao, Jun, Rency S. Varghese, Bin Zhou, et al.. (2012). LC–MS Based Serum Metabolomics for Identification of Hepatocellular Carcinoma Biomarkers in Egyptian Cohort. Journal of Proteome Research. 11(12). 5914–5923. 116 indexed citations
20.
Mor, Gil, Irene Visintin, Yinglei Lai, et al.. (2005). Serum protein markers for early detection of ovarian cancer. Proceedings of the National Academy of Sciences. 102(21). 7677–7682. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenming Gao Breakdown of academic impact, for papers by Deguang Sun Breakdown of academic impact, for papers by Egidio Iorio Breakdown of academic impact, for papers by Fenglin Lv Breakdown of academic impact, for papers by Jae Won Chang Breakdown of academic impact, for papers by Feng Su Breakdown of academic impact, for papers by Hüseyin Aktaş Breakdown of academic impact, for papers by Arthur T. Kopylov Breakdown of academic impact, for papers by Patrizia Bottoni Breakdown of academic impact, for papers by Cristina Al‐Khalili Szigyarto
Rankless by CCL
2026